These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 972015)

  • 1. Prevention of bone loss following oophorectomy in premenopausal women: a retrospective assessment of the effects of oophorectomy and a prospective controlled trial of the effects of mestranol therapy.
    Aitken JM; Hart DM; Lindsay R; Anderson JB; Smith DA; Wilson GM
    Isr J Med Sci; 1976 Jul; 12(7):607-14. PubMed ID: 972015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy.
    Aitken JM; Hart DM; Lindsay R
    Br Med J; 1973 Sep; 3(5879):515-8. PubMed ID: 4741605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menopausal bone loss and estrogen replacement.
    Meema S; Meema HE
    Isr J Med Sci; 1976 Jul; 12(7):601-6. PubMed ID: 972014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.
    Sijanovic S; Karner I
    Medscape Womens Health; 2001 Oct; 6(5):3. PubMed ID: 11698925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer.
    Eltabbakh GH; Piver MS; Hempling RE; Recio FO; Aiduk C
    Gynecol Oncol; 1997 Jul; 66(1):103-7. PubMed ID: 9234929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Lp(a) lipoprotein and lipid levels after cessation of female sex hormone production and estrogen replacement therapy.
    Kim CJ; Ryu WS; Kwak JW; Park CT; Ryoo UH
    Arch Intern Med; 1996 Mar; 156(5):500-4. PubMed ID: 8604955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oophorectomy status and bone density in older, hysterectomized women.
    Kritz-Silverstein D; Barrett-Connor E
    Am J Prev Med; 1996; 12(5):424-9. PubMed ID: 8909657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
    Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
    Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
    Bagger YZ; Tankó LB; Alexandersen P; Hansen HB; Møllgaard A; Ravn P; Qvist P; Kanis JA; Christiansen C
    Bone; 2004 Apr; 34(4):728-35. PubMed ID: 15050905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of ovarian sex steroids on bone mineral status in the oöphorectomized rat and in the human.
    Lindsay R; Aitken JM; Hart DM; Purdie D
    Postgrad Med J; 1978; 54 Suppl 2():50-8. PubMed ID: 740581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis: new hope for the future.
    Masi L; Bilezikian JP
    Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of osteoporosis with ovarian hormones.
    Lindsay R
    Ann Chir Gynaecol; 1988; 77(5-6):219-23. PubMed ID: 3076048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of hysterectomy and menopause: a prospective cohort study.
    Farquhar CM; Sadler L; Harvey SA; Stewart AW
    BJOG; 2005 Jul; 112(7):956-62. PubMed ID: 15957999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women awaiting hysterectomy: a qualitative study of issues involved in decisions about oophorectomy.
    Bhavnani V; Clarke A
    BJOG; 2003 Feb; 110(2):168-74. PubMed ID: 12618161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen treatment of patients with established postmenopausal osteoporosis.
    Lindsay R; Tohme JF
    Obstet Gynecol; 1990 Aug; 76(2):290-5. PubMed ID: 2371033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG
    CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum estradiol and follicle-stimulating hormone levels in Thai women post total abdominal hysterectomy and bilateral oophorectomy using oral 17 beta-estradiol.
    Bunyavejchevin S; Panthong C; Limpaphayom KK
    J Med Assoc Thai; 2002 Jan; 85(1):58-62. PubMed ID: 12075721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.